Novel Nanotherapy Breakthrough May Help Reduce Recurrent Heart Attacks and Stroke

 – January 20, 2014  –– 

A report in Nature Communications by the Icahn School of Medicine at Mount Sinai showcases the development of a new technology that may provide a solution to the high risk of repeat heart attacks — and potentially help save more lives. “Not only could the HDL nanotherapy potentially avert repeat heart attacks, it may also have the power to reduce recurrent strokes caused by clots in brain arteries,” said the study’s Senior Investigator, Willem Mulder, PhD, Associate Professor of Radiology in the Translational and Molecular Imaging Institute at the Icahn School of Medicine at Mount Sinai. “Levels of inflammation spike after a heart attack, which is why up to 30 percent of heart attack patients may suffer another heart attack, some while in hospital or just after discharge,” said Co-Author Zahi Fayad, PhD, Director, Translational and Molecular Imaging Institute, Vice-Chair for Research in the Department of Radiology, and Professor of Radiology and Medicine (Cardiology) at the Icahn School of Medicine at Mount Sinai.
-Dr. Willem Mulder, Associate Professor, Radiology, Translational and Molecular Imaging Institute, Icahn School of Medicine at Mount Sinai
-Dr. Zahi A. Fayad, Director, Translational and Molecular Imaging Institute, Vice-Chair for Research in the Department of Radiology, and Professor, Departments of Radiology and Medicine (Cardiology), Icahn School of Medicine at Mount Sinai
Learn more